|
1
|
Anderson P: Global use of alcohol, drugs
and tobacco. Drug Alcohol Rev. 25:489–502. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li W, Amet T, Xing Y, Yang D,
Liangpunsakul S, Puri P, Kamath PS, Sanyal AJ, Shah VH, Katz BP, et
al: Alcohol abstinence ameliorates the dysregulated immune profiles
in patients with alcoholic hepatitis: A prospective observational
study. Hepatology. 66:575–590. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gao B, Seki E, Brenner DA, Friedman S,
Cohen JI, Nagy L, Szabo G and Zakhari S: Innate immunity in
alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol.
300:G516–G525. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Miller AM, Horiguchi N, Jeong WI, Radaeva
S and Gao B: Molecular mechanisms of alcoholic liver disease:
Innate immunity and cytokines. Alcohol Clin Exp Res. 35:787–793.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pasala S, Barr T and Messaoudi I: Impact
of alcohol abuse on the adaptive immune system. Alcohol Res.
37:185–197. 2015.PubMed/NCBI
|
|
6
|
Lu Y, Yeh W and Ohashi P: LPS/TLR4 signal
transduction pathway. Cytokine. 42:145–151. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bird G, Sheron N, Goka A, Alexander G and
Williams RS: Increased plasma tumor necrosis factor in severe
alcohol hepatitis. Ann Intern Med. 112:917–920. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Degré D, Lemmers A, Gustot T, Ouziel R,
Trépo E, Demetter P, Verset L, Quertinmont E, Vercruysse V, Le
Moine O, et al: Hepatic expression of CCL2 in alcoholic liver
disease is associated with disease severity and neutrophil
infiltrates. Clin Exp Immunol. 169:302–310. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rachakonda V, Gabbert C, Raina A, Li H,
Malik S, DeLany JP and Behari J: Stratification of risk of death in
severe acute alcoholic hepatitis using a panel of adipokines and
cytokines. Alcohol Clin Exp Res. 38:2712–2721. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu J, Mcintosh H and Lin H: Chinese
medicinal herbs for chronic hepatitis B: A systematic review.
Liver. 21:280–286. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hayashi H and Sudo H: Economic importance
of licorice. Plant Biotechnol. 26:101–104. 2009. View Article : Google Scholar
|
|
12
|
Ming J and Yin A: Therapeutic effects of
glycyrrhizic acid. Nat Prod Commun. 8:415–418. 2013.PubMed/NCBI
|
|
13
|
Guo X, Liang B, Wang X, Fan FG, Jin J, Lan
R, Yang JH, Wang XC, Jin L and Cao Q: Glycyrrhizic acid attenuates
CCl4-induced hepatocyte apoptosis in rats via a p53-mediated
pathway. World J Gastroenterol. 19:3781–3791. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li JY, Cao HY, Liu P, Cheng GH and Sun MY:
Glycyrrhizic acid in the treatment of liver diseases: Literature
review. Biomed Res Int. 2014:8721392014.PubMed/NCBI
|
|
15
|
Honda H, Nagai Y, Matsunaga T, Saitoh S,
Akashi-Takamura S, Hayashi H, Fujii I, Miyake K, Muraguchi A and
Takatsu K: Glycyrrhizin and isoliquiritigenin suppress the LPS
sensor toll-like receptor 4/MD-2 complex signaling in a different
manner. J Leukoc Biol. 91:967–976. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang H, Fang ZZ, Meng R, Cao YF, Tanaka N,
Krausz KW and Gonzalez FJ: Glycyrrhizin and glycyrrhetinic acid
inhibits alpha-naphthyl isothiocyanate-induced liver injury and
bile acid cycle disruption. Toxicology. 386:133–142. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu R, Xiao Q, Cao Y and Yang J: Comparison
of the exposure of glycyrrhizin and its metabolites and the
pseudoaldosteronism after intravenous administration of alpha- and
beta-glycyrrhizin in rat. Drug Res (Stuttg). 63:620–624. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhao Y, Shi M, Liu L, Han Y, Li YQ and Li
Y: Analysis of content differences and variation trends of the
principal component isomers and related substances in the four
generations of glycyrrhizin preparations. Chin J Pharma Anal.
34:247–254. 2014.
|
|
19
|
Xu MJ, Zhou Z, Parker R and Gao B:
Targeting inflammation for the treatment of alcoholic liver
disease. Pharmacol Ther. 180:77–89. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fung P and Pyrsopoulos N: Emerging
concepts in alcoholic hepatitis. World J Hepatol. 9:567–585. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lucey M, Mathurin P and Morgan T:
Alcoholic hepatitis. N Engl J Med. 360:2758–2769. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
O'Shea R, Dasarathy S and McCullough A;
Practice Guideline Committee of the American Association for the
Study of Liver Diseases; Practice Parameters Committee of the
American College of Gastroenterology, : Alcoholic liver disease.
Hepatology. 51:307–328. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jaruga B, Hong F, Sun R, Radaeva S and Gao
B: Crucial role of IL-4/STAT6 in T cell-mediated hepatitis:
Up-regulating eotaxins and IL-5 and recruiting leukocytes. J
Immunol. 171:3233–3244. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hill D, Marsano L, Cohen D, Allen J,
Shedlofsky S and McClain CJ: Increased plasma interleukin-6
concentrations in alcoholic hepatitis. J Lab Clin Med. 119:547–552.
1992.PubMed/NCBI
|
|
25
|
Kamimura S and Tsukamoto H: Cytokine gene
expression by Kupffer cells in experimental alcoholic liver
disease. Hepatology. 22:1304–1309. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mandrekar P, Ambade A, Lim A, Szabo G and
Catalano D: An essential role for MCP-1 in alcoholic liver injury:
Regulation of pro-inflammatory cytokines and hepatic steatosis.
Hepatology. 54:2185–219. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
El Kasmi KC, Smith AM, Williams L, Neale
G, Panopoulos AD, Watowich SS, Häcker H, Foxwell BM and Murray PJ:
Cutting edge: A transcriptional repressor and corepressor induced
by the STAT3-regulated anti-inflammatory signaling pathway. J
Immunol. 179:7215–7219. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gao B, Radaeva S and Park O: Liver natural
killer and natural killer T cells: Immunobiology and emerging roles
in liver diseases. J Leukoc Biol. 86:513–528. 2009. View Article : Google Scholar : PubMed/NCBI
|
